Reishi, Ganoderma Lucidum and Ganoderma Tsugae: Bioactive Substances and Medicinal Effects

Simple item page
dc.contributor.authorTakashi Mizuno
dc.contributor.authorGuanying Wang
dc.contributor.authorJie Zhang
dc.contributor.authorHirokazu Kawagishi
dc.contributor.authorTsuyoshi Nishitoba
dc.contributor.authorJingxuan Li
dc.date.accessioned2014-09-15T05:35:21Z
dc.date.available2014-09-15T05:35:21Z
dc.date.issued1995
dc.description.abstractReishi, Ganoderma sp., has been known in Japan, China, and other countries as a food and raw material for the development of drugs. Recent studies have shown that the carcinostatic substance in Reishi is a polysaccharide, β-(l —3)-o-glucan. This polysaccharide seems to haye promise as a new type of carcinostatic agent which might be useful in immunotherapy. Unlike chemicals used in chemotherapy, it has few toxic side effects because its effect is based on immuno-logical enhancement in the host. Reishi also seems to contain other substances which reduce blood pressure, blood cholesterol, and blood sugar levels; and inhibit platelet aggregation, etc. Some lanostane triterpenoids have been isolated from Ganoderma lucidum and G. applanatum, and drimane sesquiter penoids from Cryptoporus volvatus. These are highly oxidized compounds which show interesting biological activities.en_US
dc.identifier.citationFood Reviews International, 11(1),151-166, 1995en_US
dc.identifier.urihttp://hdl.handle.net/123456789/5697
dc.language.isoenen_US
dc.titleReishi, Ganoderma Lucidum and Ganoderma Tsugae: Bioactive Substances and Medicinal Effectsen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
reishi ganoderma lucidum and ganoderma.pdf
Size:
11.47 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Reprints